CDH5 and rheumatoid arthritis: Endothelial cell sphingosine 1-phophate receptor 1 restrains VE-cadherin cleavage and attenuates experimental inflammatory arthritis, supporting further evalualation as a potential target for rheumatoid arthritis treatment.